🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Висконсин

Kliničke studije za Немалоклетни карцином плућа u državi Висконсин

44 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u državi Висконсин.

Gradovi u državi Висконсин

Zvanični tekst studije (na engleskom)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Mercyhealth, Janesville
Тражи се учесникФаза 3
Узраст од 18 до 100 · Оба пола · Ажурирано 13. 11. 2026. · NCT05920356

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • UW Health Carbone Cancer Center, Madison
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07488676

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Aurora Cancer Care-Grafton, Grafton
  • Aurora BayCare Medical Center, Green Bay
  • Aurora St. Luke's Medical Center, Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Duluth Clinic Ashland, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • и још 18
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
  • и још 52
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  • Circuit Clinical/SSM Health Dean Medical Group ( Site 0129), Madison
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06345729

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  • Froedtert Hospital - Clinical Cancer Center, Milwaukee
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06914128

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

  • Research Site, Eau Claire
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07291037

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  • Gundersen Health System ( Site 3200), La Crosse
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07513376

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

  • Duluth Clinic Ashland, Ashland
  • Bellin Memorial Hospital, Green Bay
  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • и још 9
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07388524

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • Ascension Network - St Elizabeth's Hospital, Appleton
  • Ascension Columbia St. Mary's, Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • University Hospital and UW Health Clinics, Madison
  • Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Aspirus Langlade Hospital, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Saint Elizabeth Hospital, Appleton
  • и још 61
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Marshfield Clinic-Chippewa Center, Chippewa Falls
  • Aurora Saint Luke's South Shore, Cudahy
  • и још 27
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT03191149

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • и још 7
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07293247

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • Gundersen Lutheran Medical Center, La Crosse
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06712316

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

  • Research Site, Appleton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06357533

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT02984761

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Local Institution - 0135, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07680764

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  • HSHS St. Vincent Hospital Regional Cancer Center, Green Bay
  • Marshfield Medical Center - Marshfield, Marshfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07361510

Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06305715

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • University of Wisconsin (Carbone Cancer Center), Madison
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06026410

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

  • Gundersen Lutheran Medical Center, La Crosse
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07393555

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Duluth Clinic Ashland, Ashland
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Aurora Saint Luke's South Shore, Cudahy
  • и још 18
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Duluth Clinic Ashland, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • Gundersen Lutheran Medical Center, La Crosse
  • и још 5
Тражи се учесникФаза 2
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  • The Board of Regents of the University of Wisconsin, Madison
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07070232

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Duluth Clinic Ashland, Ashland
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Aurora Saint Luke's South Shore, Cudahy
  • и још 28
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Minnesota Oncology Hematology, P.A., Hudson
  • Froedtert Hospital/Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #33, Milwaukee
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Wisconsin Institute for Medical Research, Madison
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06625775

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Milwaukee
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT05877599

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

  • Research Site, Schofield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06868277

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

  • Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06855771

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • ThedaCare Regional Cancer Center, Appleton
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • Research Site, Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06350097

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • University of Wisconsin- Madison, Madison
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT05592626

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

  • Northwest Wisconsin Cancer Center, Ashland
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06686771

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.